Modulation of butyrate transport in Caco-2 cells Pedro GonçalvesJoão Ricardo AraújoFátima Martel Original Article 21 November 2008 Pages: 325 - 336
Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2) Oliver ZolkThomas F. SolbachMartin F. Fromm Original Article 11 November 2008 Pages: 337 - 348
Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium Ulrich GergsJoachim NeumannStephanie Läer Original Article 11 November 2008 Pages: 349 - 359
Effects of gabapentin and pregabalin on K+-evoked 3H-GABA and 3H-glutamate release from human neocortical synaptosomes B. BrawekM. LöfflerT. J. Feuerstein Original Article 11 November 2008 Pages: 361 - 369
Positive allosteric modulatory effects of ajulemic acid at strychnine-sensitive glycine α1- and α1β-receptors Jörg AhrensMartin LeuwerGertrud Haeseler Original Article 05 November 2008 Pages: 371 - 378
Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (−)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium Alejandro Galindo-TovarMaria Luisa VargasAlberto J. Kaumann Short Communication 14 November 2008 Pages: 379 - 384
How reliable are G-protein-coupled receptor antibodies? Martin C. MichelThomas WielandGozoh Tsujimoto Editorial Open access 27 January 2009 Pages: 385 - 388
Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice Gitte JositschTamara PapadakisWolfgang Kummer Short Communication 31 October 2008 Pages: 389 - 395
Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors Wisuit PradidarcheepJan StallenWouter H. Lamers Special Article Open access 07 February 2009 Pages: 397 - 402
Lack of specificity of antibodies directed against human beta-adrenergic receptors Nazha HamdaniJolanda van der Velden Short Communication Open access 22 January 2009 Pages: 403 - 407
Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific Brian C. JensenPhilip M. SwigartPaul C. Simpson Special Article 07 November 2008 Pages: 409 - 412
Should we be cautious on the use of commercially available antibodies to dopamine receptors? Serena BodeiNicola ArrighiSandra Sigala Short Communication 19 December 2008 Pages: 413 - 415
Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice Xiaoying LuTamas Bartfai Short Communication 22 January 2009 Pages: 417 - 420
Where is TRPV1 expressed in the bladder, do we see the real channel? Wouter EveraertsM. Rosario SepúlvedaDirk De Ridder Short Communication 20 January 2009 Pages: 421 - 425
Distribution and regulation of protein expression of the free fatty acid receptor GPR120 Satoshi MiyauchiAkira HirasawaGozoh Tsujimoto Original Article 15 January 2009 Pages: 427 - 434
